HomeAbout
About
Time to first decision without review:
8 days (median)
Time to first decision with review:
26 days (median)
Time from acceptance to publication:
28 days (median)
Total content views:
4,766
Total Altmetric mentions:
569
Aims and scope
eGastroenterology dedicates itself to improving clinical diagnosis and treatment of gastrointestinal, hepatobiliary, pancreatic, and esophageal diseases. The main aim of eGastroenterology is to provide a platform for communication among researchers and clinicians engaged in the fields of basic, clinical, and translational medicine research in gastroenterology and hepatology. The ultimate goal is to promote the translation of basic science into clinical practice and to benefit patients through the best scientific evidence available.
eGastroenterology publishes up-to-date research of prevention, diagnosis, and treatment advances in all sub-fields of digestive medicine and surgery with:
- Original research
- Review
- Short report
- Guideline
- Editorial
- Perspective
- Liver diseases
- Viral hepatitis
- MASLD/NAFLD
- Alcohol-related liver diseases
- Cholestatic and biliary diseases
- Hepatobiliary and pancreatic cancer
- Pancreas diseases
- Esophageal diseases
- Hepato-pancreato-biliary surgery
- Translational gastroenterology and hepatology
- Gastrointestinal disorders
- Irritable bowel syndrome
- Gut microbiota
- Inflammatory bowel disease
- GI cancer
- Gastrointestinal endoscope
- Gut immunity
- Nutrition
- Gastrointestinal surgery
- Epidemiology
Editorial Board
For information about the eGastroenterology editorial team, please refer to the Editorial Board page.
Journal information
Publication Model
Open access
Frequency
Continuous Publication
Launch date
2023
Indexed by
DOAJ
Peer review model
Open Peer Review
Online ISSN
2976-7296
Journal Statistics 2023
Speed
Time to first decision without review: 8 days (median)
Time to first decision with review: 26 days (median)
Time from acceptance to publication: 28 days (median)
Impact
Impact Factor category:
Impact Factor (JCR):
Journal Citation Indicator (JCI):
Eigenfactor Score:
Citescore:
Citescore rank:
Scimago Journal Rank (SJR):
Reach
Total content views: 4,766
Total altmetric mentions: 569
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Affiliations
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. BMJ Publishing Group has been a member since 2009.
Open Access articles in BMJ Public Health are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.
Ownership
eGastroenterology is published by BMJ on behalf of the First Hospital of Jilin University. The hospital is a large comprehensive Top-A hospital that integrates medical treatment, education, scientific research, disease prevention, health care, and rehabilitation services.
The First Hospital of Jilin University was initially founded with the assistance of Dr. Norman Bethune, and the hospital has since consistently upheld, promoted, and practised the spirit of Bethune. This commitment to excellence and innovation in patient care, education, and research is reflected in eGastroenterology's dedication to publishing high-quality research in the field of gastroenterology and hepatology.